The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, yielding billions in revenue , its intellectual property lapse created a deluge https://binksites.com/story11302874/copyright-s-pill-and-pharma-a-risky-venture